Security Snapshot

IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) Institutional Ownership

CUSIP: 46333X108

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

167

Shares (Excl. Options)

108.48MFull value: 108,478,150 · shares · 30 Sep 2026

Price

$3.97

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-6,191,688
Value change
-$24,840,869
Number of holders
167
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
165,198,238
SEC-reported price per share
$3.62
Insider filing price
$3.62
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value is tracked under CUSIP 46333X108.
  • 167 institutions reported positions in Q3 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 212 to 167 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $675.82MFull value: $675,820,985 · USD · 30 Jun 2026
    to
    $430.34MFull value: $430,344,166 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 167 institutions filings for Q3 2026.

Open SEC evidence

Security key

46333X108

13F reference period

Q3 2026

13F holders

167

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
IRWD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% +2.1% $10,855,426 +$338,999 16,202,129 +3.2% The Vanguard Group 30 Jun 2025
ARMISTICE CAPITAL, LLC 9.1% +8.1% $54,600,000 +$3,887,520 15,000,000 +7.7% Armistice Capital, LLC 30 Sep 2026
BlackRock, Inc. 8.1% +14% $56,302,721 +$8,795,401 13,373,568 +19% BlackRock, Inc. 30 Jun 2026
Sarissa Capital Management LP 5.8% $31,735,012 9,444,944 Alexander J. Denner 17 Mar 2026
RENAISSANCE TECHNOLOGIES LLC 5.4% $7,565,534 8,597,198 Renaissance Technologies LLC 15 May 2024
STATE STREET CORP 4.1% -26% $24,474,537 -$7,592,410 6,723,774 -24% STATE STREET CORPORATION 30 Sep 2026
BANK OF AMERICA CORP /DE/ 3.2% -48% $20,720,681 -$18,829,869 5,219,315 -48% BANK OF AMERICA CORP /DE/ 30 Sep 2026
BARCLAYS PLC 2% -70% $4,149,704 -$10,435,649 3,167,713 -72% Barclays PLC 30 Sep 2025
Pacer Advisors, Inc. 1.1% -89% $1,574,406 -$8,748,672 1,789,098 -85% Pacer US Small Cap Cash Cows ETF 31 Mar 2025
As of 30 Sep 2026, 167 institutional investors reported holding
108.48MFull value: 108,478,150 · shares · 30 Sep 2026
shares of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD). This represents 66% of the company’s total
165.2MFull value: 165,198,238 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
52%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 9.1% 15,000,000 2% $59,550,000
Sarissa Capital Management LP 5.6% 9,188,635 24% $36,478,881
RENAISSANCE TECHNOLOGIES LLC 4.9% 8,041,792 0.04% $31,925,914
STATE STREET CORP 4.1% 6,723,774 0% $26,693,383
VANGUARD CAPITAL MANAGEMENT LLC 4% 6,634,751 0% $26,339,961
BANK OF AMERICA CORP /DE/ 3.2% 5,218,957 0% $20,719,260
VANGUARD PORTFOLIO MANAGEMENT LLC 3.1% 5,063,802 0% $20,103,294
GEODE CAPITAL MANAGEMENT, LLC 2.4% 3,918,000 0% $15,558,048
TWO SIGMA INVESTMENTS, LP 2.3% 3,854,914 0.01% $15,304,009
FEDERATED HERMES, INC. 2% 3,225,141 0.02% $12,803,809
GOLDMAN SACHS GROUP INC 1.7% 2,743,317 0% $10,890,969
DIMENSIONAL FUND ADVISORS LP 1.6% 2,654,580 0% $10,540,388
MARSHALL WACE, LLP 1.6% 2,567,468 0.01% $10,192,848
MACKENZIE FINANCIAL CORP 1.4% 2,322,690 0.01% $9,221,079
Connor, Clark & Lunn Investment Management Ltd. 1.1% 1,750,075 0.01% $6,947,798
VANGUARD FIDUCIARY TRUST CO 0.65% 1,081,851 0% $4,294,948
Qube Research & Technologies Ltd 0.52% 865,395 0% $3,435,618
RAYMOND JAMES FINANCIAL INC 0.49% 810,389 0% $3,217,243
STATE OF WISCONSIN INVESTMENT BOARD 0.46% 765,336 0.01% $3,038,384
Hillsdale Investment Management Inc. 0.45% 746,554 0.07% $2,963,820
WELLINGTON MANAGEMENT GROUP LLP 0.34% 569,140 0% $2,259,486
Vanguard Global Advisers, LLC 0.34% 559,758 0% $2,222,239
CWA Asset Management Group, LLC 0.3% 498,643 0.06% $1,979,613
WEDGE CAPITAL MANAGEMENT L L P/NC 0.26% 435,650 0.03% $1,729,531
SEGALL BRYANT & HAMILL, LLC 0.25% 408,064 0.02% $1,620,014

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 108,478,150 $430,344,166 -$24,840,869 $3.97 167
2026 Q2 160,555,035 $675,820,985 -$1,071,812 $4.21 212
2026 Q1 161,500,139 $566,792,745 +$30,731,831 $3.51 226
2025 Q4 153,978,212 $519,062,006 +$36,443,345 $3.37 196
2025 Q3 148,541,007 $194,617,095 +$6,212,194 $1.31 160
2025 Q2 146,448,573 $105,056,220 -$19,990,203 $0.72 151
2025 Q1 155,587,802 $228,692,691 -$26,001,186 $1.47 200
2024 Q4 164,213,918 $727,463,387 +$1,737,232 $4.43 222
2024 Q3 163,472,233 $673,496,034 -$53,233,700 $4.12 218
2024 Q2 171,468,668 $1,117,746,593 -$10,390,681 $6.52 226
2024 Q1 172,118,333 $1,499,071,284 +$34,523,403 $8.71 259
2023 Q4 164,989,974 $1,887,503,875 +$27,460,717 $11.44 248
2023 Q3 162,344,641 $1,563,374,016 -$47,770,085 $9.63 248
2023 Q2 166,095,520 $1,767,006,761 +$4,551,974 $10.64 249
2023 Q1 165,499,147 $1,741,215,310 -$25,432,141 $10.52 253
2022 Q4 167,942,496 $2,080,711,382 -$11,969,237 $12.39 248
2022 Q3 169,832,029 $1,759,668,119 -$66,873,989 $10.36 234
2022 Q2 175,222,861 $2,020,512,624 +$105,001,683 $11.53 229
2022 Q1 166,602,554 $2,094,673,928 -$62,666,606 $12.58 205
2021 Q4 171,908,670 $2,002,842,425 -$78,175,850 $11.66 206
2021 Q3 177,433,352 $2,315,405,743 +$38,243,173 $13.06 216
2021 Q2 174,523,300 $2,245,931,885 +$54,432,994 $12.87 200
2021 Q1 171,145,457 $1,913,286,723 -$10,293,889 $11.18 202
2020 Q4 171,628,514 $1,954,636,964 -$289,602 $11.39 191
2020 Q3 179,160,124 $1,611,634,384 -$60,043,147 $9.00 183
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .